W Tang1, X Wang2, Y Chen1, J Zhang1, Y Chen1, Z Lin3. 1. Department of Neurosurgery, The First Affiliated Hospital of Fujian Medical University, 20 Cazhong Road, Fuzhou, Fujian, China. 2. Department of Pathology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China. 3. Department of Neurosurgery, The First Affiliated Hospital of Fujian Medical University, 20 Cazhong Road, Fuzhou, Fujian, China; Department of Neurosurgery, Beijing Sanbo Brain Hospital, 50 Xiangshanyikesong Road, Haidian District, Beijing, China. Electronic address: lzx1967@sina.com.
Abstract
PURPOSE OF THE STUDY: Previous studies have shown that the pattern of recurrence for glioma is related to the direction of glioma cell invasion. Recent studies demonstrated that the CXCL12/CXCR4 signaling pathway mediates cellular invasion in glioma. Therefore, in this study, we investigated the possible relationship between CXCL12/CXCR4 expression and recurrence pattern in glioma. PATIENTS AND METHODS: Immunohistochemical techniques were used to assess CXCL12/CXCR4 expression in 42 glioma tissues following total resection. According to magnetic resonance imaging (MRI) of gliomas, the recurrence pattern was classified as close or distant pattern. The relationship between recurrence pattern and CXCL12/CXCR4 expression were initially examined by Chi-squared analysis. The prognostic significance of CXCL12 and CXCR4 was determined by log-rank tests and COX proportional hazards model. RESULTS: CXCL12 was expressed mainly in vascular endothelial cells and CXCR4 was expressed mainly in tumor cells. The recurrence pattern was significantly related to the expression level of CXCL12 in vascular endothelial cells (P=0.002) and CXCR4 in tumor cells (P=0.004). However, CXCL12 and CXCR4 were not independent prognostic factors for progression-free survival or overall survival in glioma patients. CONCLUSION: The glioma recurrence pattern is related to CXCL12 expression levels in vascular endothelial cells and CXCR4 expression levels in tumor cells; thus, implicating the CXCL12/CXCR4 signaling pathway as a potential target for glioma therapy.
PURPOSE OF THE STUDY: Previous studies have shown that the pattern of recurrence for glioma is related to the direction of glioma cell invasion. Recent studies demonstrated that the CXCL12/CXCR4 signaling pathway mediates cellular invasion in glioma. Therefore, in this study, we investigated the possible relationship between CXCL12/CXCR4 expression and recurrence pattern in glioma. PATIENTS AND METHODS: Immunohistochemical techniques were used to assess CXCL12/CXCR4 expression in 42 glioma tissues following total resection. According to magnetic resonance imaging (MRI) of gliomas, the recurrence pattern was classified as close or distant pattern. The relationship between recurrence pattern and CXCL12/CXCR4 expression were initially examined by Chi-squared analysis. The prognostic significance of CXCL12 and CXCR4 was determined by log-rank tests and COX proportional hazards model. RESULTS:CXCL12 was expressed mainly in vascular endothelial cells and CXCR4 was expressed mainly in tumor cells. The recurrence pattern was significantly related to the expression level of CXCL12 in vascular endothelial cells (P=0.002) and CXCR4 in tumor cells (P=0.004). However, CXCL12 and CXCR4 were not independent prognostic factors for progression-free survival or overall survival in gliomapatients. CONCLUSION: The glioma recurrence pattern is related to CXCL12 expression levels in vascular endothelial cells and CXCR4 expression levels in tumor cells; thus, implicating the CXCL12/CXCR4 signaling pathway as a potential target for glioma therapy.
Authors: Jean-Pierre Gagner; Yasmeen Sarfraz; Valerio Ortenzi; Fawaz M Alotaibi; Luis A Chiriboga; Awab T Tayyib; Garry J Douglas; Eric Chevalier; Barbara Romagnoli; Gérald Tuffin; Michel Schmitt; Guillaume Lemercier; Klaus Dembowsky; David Zagzag Journal: Am J Pathol Date: 2017-07-20 Impact factor: 4.307
Authors: Harsh Samarendra; Keaton Jones; Tatjana Petrinic; Michael A Silva; Srikanth Reddy; Zahir Soonawalla; Alex Gordon-Weeks Journal: Br J Cancer Date: 2017-05-23 Impact factor: 7.640
Authors: Eva M García-Cuesta; César A Santiago; Jesús Vallejo-Díaz; Yasmina Juarranz; José Miguel Rodríguez-Frade; Mario Mellado Journal: Front Endocrinol (Lausanne) Date: 2019-08-27 Impact factor: 5.555
Authors: Lorena Favaro Pavon; Tatiana Tais Sibov; Silvia Regina Caminada de Toledo; Daniela Mara de Oliveira; Francisco Romero Cabral; Jean Gabriel de Souza; Pamela Boufleur; Luciana C Marti; Jackeline Moraes Malheiros; Edgar Ferreira da Cruz; Fernando F Paiva; Suzana M F Malheiros; Manoel A de Paiva Neto; Alberto Tannús; Sérgio Mascarenhas de Oliveira; Nasjla Saba Silva; Andrea Maria Cappellano; Antonio Sérgio Petrilli; Ana Marisa Chudzinski-Tavassi; Sérgio Cavalheiro Journal: Oncotarget Date: 2018-04-24